IPO registrations (S-1, F-1) · Registrants
ARATANA THERAPEUTICS, INC.
- SEC CIK
- 1509190 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2013-03-20, last 2014-01-28; 2 initial registrations, 8 amendments
- Outcome
- Final prospectus filed 2013-06-27; declared effective 2013-06-26
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 11400 TOMAHAWK CREEK PARKWAY, SUITE 340, Leawood, KS 66211
- EIN
- 38-3826477
- EDGAR entity type
- operating
- Insiders and CEO pay
- ARATANA THERAPEUTICS, INC. on the corporate pages
On this site
- Business registration: ARATANA THERAPEUTICS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: ARATANA THERAPEUTICS, INC. EXACT (EIN (EXACT))
- SEC filer: ARATANA THERAPEUTICS, INC. EXACT (CIK (EXACT))
- Person page: Craig A Barbarosh Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Irvine O Hockaday Jr Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Robert P Roche Jr Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 17
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2013-03-20 | S-1 | S-1 (registration) | ARATANA THERAPEUTICS, INC. | 0001193125-13-116272 ↗ |
| 2013-04-11 | S-1/A | S-1/A (amendment) | ARATANA THERAPEUTICS, INC. | 0001193125-13-151157 ↗ |
| 2013-04-30 | S-1/A | S-1/A (amendment) | ARATANA THERAPEUTICS, INC. | 0001193125-13-183520 ↗ |
| 2013-05-20 | S-1/A | S-1/A (amendment) | ARATANA THERAPEUTICS, INC. | 0001193125-13-228106 ↗ |
| 2013-05-23 | S-1/A | S-1/A (amendment) | ARATANA THERAPEUTICS, INC. | 0001193125-13-232510 ↗ |
| 2013-06-06 | S-1/A | S-1/A (amendment) | ARATANA THERAPEUTICS, INC. | 0001193125-13-250169 ↗ |
| 2013-06-26 | S-1/A | S-1/A (amendment) | ARATANA THERAPEUTICS, INC. | 0001193125-13-271755 ↗ |
| 2013-06-26 | EFFECT | EFFECT (declared effective) | ARATANA THERAPEUTICS, INC. | 9999999995-13-001921 ↗ |
| 2013-06-27 | 424B4 | 424B4 (final prospectus) | ARATANA THERAPEUTICS, INC. | 0001193125-13-274945 ↗ |
| 2014-01-13 | S-1 | S-1 (registration) | ARATANA THERAPEUTICS, INC. | 0001193125-14-008945 ↗ |
| 2014-01-22 | S-1/A | S-1/A (amendment) | ARATANA THERAPEUTICS, INC. | 0001193125-14-017482 ↗ |
| 2014-01-28 | S-1/A | S-1/A (amendment) | ARATANA THERAPEUTICS, INC. | 0001193125-14-023235 ↗ |
| 2014-01-28 | EFFECT | EFFECT (declared effective) | ARATANA THERAPEUTICS, INC. | 9999999995-14-000236 ↗ |
| 2014-01-29 | S-1MEF | S-1MEF (added securities) | ARATANA THERAPEUTICS, INC. | 0001193125-14-025271 ↗ |
| 2014-01-29 | 424B1 | 424B1 (final prospectus) | ARATANA THERAPEUTICS, INC. | 0001193125-14-026608 ↗ |
| 2014-01-31 | 424B1 | 424B1 (final prospectus) | ARATANA THERAPEUTICS, INC. | 0001193125-14-031136 ↗ |
| 2014-07-30 | EFFECT | EFFECT (declared effective) | ARATANA THERAPEUTICS, INC. | 9999999995-14-002315 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Avalon Ventures IX GP, LLC | TenPercentOwner | 4 | 2013–2014 | ||
| Avalon Ventures IX, L.P. | TenPercentOwner | 4 | 2013–2014 | ||
| EVNIN LUKE | TenPercentOwner | 4 | 2013–2014 | ||
| Foley Todd | TenPercentOwner | 5 | 2013–2014 | ||
| GADICKE ANSBERT | TenPercentOwner | 5 | 2013–2014 | ||
| GERBER ROBERT BENTHALL JR | Director | 5 | 2013–2017 | ||
| HEINEN ERNST | Officer | Chief Development Officer; SEE REMARKS | 18 | 2013–2019 | |
| KAILIAN VAUGHN M | TenPercentOwner | 4 | 2013–2014 | ||
| Lichter Jay | Director; Director,TenPercentOwner | 8 | 2013–2015 | ||
| MAWHINNEY LOUISE | Officer | CHIEF FINANCIAL OFFICER | 3 | 2013 | |
| MEEUSEN RONALD L | Director; Director,TenPercentOwner | 4 | 2013–2014 | ||
| MPM ASSET MANAGEMENT INVESTORS BV5 LLC | TenPercentOwner | 4 | 2013–2014 | ||
| MPM BIOVENTURES V GP LLC | TenPercentOwner | 4 | 2013–2014 | ||
| MPM BIOVENTURES V LLC | TenPercentOwner | 4 | 2013–2014 | ||
| MPM BIOVENTURES V, L.P. | TenPercentOwner | 4 | 2013–2014 | ||
| Rhodes Linda | Director,Officer; Officer | CHIEF SCIENTIFIC OFFICER | 10 | 2013–2015 | |
| Scopa James Paul | TenPercentOwner | 4 | 2013–2014 | ||
| STEPHANUS JULIA A | Officer | CHIEF COMMERCIAL OFFICER | 17 | 2013–2016 | |
| St Peter Steven | Director,Officer | PRESIDENT AND CEO | 28 | 2013–2018 | |
| TOOMAN CRAIG A | Director; Director,Officer; Officer | CHIEF FINANCIAL OFFICER; President and CEO; President, CEO and CFO | 16 | 2013–2019 | |
| Vander Vort John | Director; Director,TenPercentOwner | 10 | 2013–2019 | ||
| YARNO WENDY L | Director | 9 | 2013–2019 | ||
| Brege Laura | Director | 6 | 2014–2018 | ||
| RAINES MERILEE | Director | 8 | 2014–2019 | ||
| Brinkley David L | Director | 8 | 2014–2019 | ||
| ROCHE ROBERT P JR | Director | 8 | 2014–2019 | person page Fuzzy | |
| Hockaday Irvine O Jr | Director | 8 | 2014–2019 | person page Fuzzy | |
| Standridge Brent | Officer | Chief Operating Officer | 6 | 2016–2018 | |
| Broadfin Capital, LLC | TenPercentOwner | 5 | 2017–2019 | ||
| Broadfin Healthcare Master Fund Ltd | TenPercentOwner | 5 | 2017–2019 | ||
| KOTLER KEVIN | TenPercentOwner | 5 | 2017–2019 | ||
| Barbarosh Craig A. | Director | 4 | 2018–2019 | person page Fuzzy | |
| ROBINSON LOWELL W | Director | 4 | 2018–2019 | ||
| AYRES JOHN C | Officer | SEE REMARKS | 4 | 2019 | |
| READY CHRISTOPHER T | Officer | VP of Sales and Marketing | 3 | 2019 | |
| HELLUMS RHONDA LYNETTE | Officer | CHIEF FINANCIAL OFFICER | 3 | 2019 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.